113 related articles for article (PubMed ID: 36315382)
1. Intercomparison of S-Factor values calculated in Zubal voxelized phantom for eleven radionuclides commonly used in targeted prostate cancer therapy.
El Bakkali J; Doudouh A; El Bardouni T; Ghalbzouri TEL; Yerrou R
Phys Eng Sci Med; 2022 Dec; 45(4):1251-1256. PubMed ID: 36315382
[TBL] [Abstract][Full Text] [Related]
2. InterDosi simulations of photon and alpha specific absorbed fractions in zubal voxelized phantom.
El Bakkali J; Doudouh A; El Bardouni T
Appl Radiat Isot; 2021 Oct; 176():109838. PubMed ID: 34175546
[TBL] [Abstract][Full Text] [Related]
3. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
4. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
Falzone N; Ackerman NL; Rosales LF; Bernal MA; Liu X; Peeters SG; Soto MS; Corroyer-Dulmont A; Bernaudin M; Grimoin E; Touzani O; Sibson NR; Vallis KA
Theranostics; 2018; 8(1):292-303. PubMed ID: 29290808
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Targeted Radionuclide Therapy of Bone Metastases Based on β-Emitting and α-Emitting Radionuclides.
Sadremomtaz A; Masoumi M
J Med Imaging Radiat Sci; 2019 Jun; 50(2):272-279. PubMed ID: 31176435
[TBL] [Abstract][Full Text] [Related]
7. A new rectal model for dosimetry applications.
Mardirossian G; Tagesson M; Blanco P; Bouchet LG; Stabin M; Yoriyaz H; Baza S; Ljungberg M; Strand SE; Brill AB
J Nucl Med; 1999 Sep; 40(9):1524-31. PubMed ID: 10492375
[TBL] [Abstract][Full Text] [Related]
8. Estimation of electron-specific absorbed fractions with the InterDosi code using ICRP adult female voxel-based phantom.
El Bakkali J; Bouyakhlef K; Doudouh A; El Bardouni T
Appl Radiat Isot; 2022 Apr; 182():110145. PubMed ID: 35180525
[TBL] [Abstract][Full Text] [Related]
9. Preclinical efficacy of hK2 targeted [
Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
[TBL] [Abstract][Full Text] [Related]
10. S-values estimation of positron-emitting radionuclides in the ICRP voxel-based adult male organs using a new Geant4-based code DoseCalcs: validation study.
El Ghalbzouri T; El Bardouni T; El Bakkali J
Phys Eng Sci Med; 2023 Jun; 46(2):645-657. PubMed ID: 36940065
[TBL] [Abstract][Full Text] [Related]
11. Implementation of dose point kernel (DPK) for dose optimization of
Peer-Firozjaei M; Tajik-Mansoury MA; Geramifar P; Parach AA; Zarifi S
Appl Radiat Isot; 2021 Jul; 173():109673. PubMed ID: 33812266
[TBL] [Abstract][Full Text] [Related]
12. Fast beta-emitter Monte Carlo simulations and full patient dose calculations of targeted radionuclide therapy: introducing egs_mird.
Martinov MP; Opara C; Thomson RM; Lee TY
Med Phys; 2022 Sep; 49(9):6137-6149. PubMed ID: 35650012
[TBL] [Abstract][Full Text] [Related]
13. An assessment of bone-seeking radionuclides for palliation of metastatic bone pain in a vertebral model.
Sadremomtaz A; Masoumi M
Ann Nucl Med; 2019 Apr; 33(4):252-264. PubMed ID: 30659480
[TBL] [Abstract][Full Text] [Related]
14. Differences in the S value between male and female murine model for diagnostic, therapeutic and theragnostic radionuclides.
López-Coello LI; Torres-García E; Díaz-Sánchez LE; Oros-Pantoja R; Aranda-Lara L
Appl Radiat Isot; 2019 Apr; 146():61-65. PubMed ID: 30753986
[TBL] [Abstract][Full Text] [Related]
15. Practical Nuclear Medicine and Utility of Phantoms for Internal Dosimetry: XCAT Compared with Zubal.
Fallahpoor M; Abbasi M; Kalantari F; Parach AA; Sen A
Radiat Prot Dosimetry; 2017 Apr; 174(2):191-197. PubMed ID: 27247443
[TBL] [Abstract][Full Text] [Related]
16. Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides.
Serencsits B; Chu BP; Pandit-Taskar N; McDevitt MR; Dauer LT
J Nucl Med Technol; 2022 Mar; 50(1):10-16. PubMed ID: 34750237
[No Abstract] [Full Text] [Related]
17. Evaluating the Application of Tissue-Specific Dose Kernels Instead of Water Dose Kernels in Internal Dosimetry: A Monte Carlo Study.
Khazaee Moghadam M; Kamali Asl A; Geramifar P; Zaidi H
Cancer Biother Radiopharm; 2016 Dec; 31(10):367-379. PubMed ID: 27996311
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Banerjee SR; Minn I; Kumar V; Josefsson A; Lisok A; Brummet M; Chen J; Kiess AP; Baidoo K; Brayton C; Mease RC; Brechbiel M; Sgouros G; Hobbs RF; Pomper MG
J Nucl Med; 2020 Jan; 61(1):80-88. PubMed ID: 31253744
[TBL] [Abstract][Full Text] [Related]
19. Pediatric radiation dosimetry for positron-emitting radionuclides using anthropomorphic phantoms.
Xie T; Bolch WE; Lee C; Zaidi H
Med Phys; 2013 Oct; 40(10):102502. PubMed ID: 24089923
[TBL] [Abstract][Full Text] [Related]
20. Concerning the health effects of internally deposited radionuclides.
Raabe OG
Health Phys; 2010 Mar; 98(3):515-36. PubMed ID: 20147792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
